南京医药 (600713.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(南京医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2022年一季报2021年年报2021年三季报2021年中报2021年一季报2020年年报2020年三季报2020年中报2020年一季报
主要指标:
 营业收入(元) 11,700,603,929.1345,123,195,144.2933,396,828,052.1221,896,767,554.6011,084,756,655.2039,817,363,611.3129,073,882,652.5218,272,213,112.448,789,021,740.17
 营业利润(元) 212,662,932.22845,713,370.09589,568,410.39379,464,138.45162,109,337.85676,260,896.48498,952,964.63308,718,355.96128,704,937.54
 利润总额(元) 207,242,030.91838,866,324.95583,680,419.15373,223,998.62159,358,357.78677,799,074.68487,815,511.90301,449,766.65125,180,790.46
 净利润(元) 151,913,357.09610,551,837.29423,499,308.83268,241,764.60116,156,306.99470,037,796.67346,439,701.68209,624,526.0287,253,723.54
 归属于母公司股东的净利润(元) 132,553,759.97505,182,814.26346,327,064.69222,358,383.95101,956,075.35376,413,112.54282,680,399.81172,695,390.3975,959,213.16
盈利能力:
 销售毛利率(%) 6.236.516.456.345.906.366.526.445.97
 销售净利率(%) 1.301.351.271.231.051.181.191.150.99
 净资产收益率(%) 2.6411.408.015.282.41----
 总资产报酬率ROA(%) 1.145.203.652.491.01----
 投入资本回报率ROIC(%) 0.933.772.631.680.733.232.531.630.67
营运能力:
 存货周转率(次) 2.219.837.294.822.31----
 应收账款周转率(次) 1.024.543.002.181.15----
 总资产周转率(次) 0.441.831.340.930.44----
偿债能力:
 资产负债率(%) 77.3479.7881.2780.5480.8379.4179.2578.5080.92
 股东权益比率(%) 20.2817.7916.5416.9816.8418.1918.4119.1017.00
 已获利息倍数(倍) 3.062.902.812.772.722.882.802.562.23
 流动比率 1.331.341.311.321.251.231.231.241.17
 速动比率 1.001.021.031.010.960.940.950.950.90
发展能力:
 营业收入增长率(%) 5.5613.3314.8719.8426.127.164.992.000.61
 营业利润增长率(%) 31.1825.0618.1622.9225.9527.9017.817.893.42
 税后利润增长率(%) 30.0134.2122.5228.7634.228.50-3.968.115.22
 净资产增长率(%) 31.768.195.455.494.866.088.199.0910.69
 总资产增长率(%) 9.3710.5817.3718.655.876.57-3.94-2.619.88

前瞻产业研究院